Schedule 13G ownership disclosure

FREELINE THERAPEUTICS HLDGS

Security class unavailable · CUSIP: 35655L206

Event date: 2023-07-12

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
8.5000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001319244-23-000057
Form type
SC 13G
Filer
Freeline Therapeutics Holdings plc
CIK
CIK 1810031
Filed
Jul 17, 2023
Reporting period
Jul 12, 2023
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub